Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -79.77 | 29.00 |
| PEG Ratio (TTM) | 1.05 | 1.71 |
| P/S Ratio (TTM) | 0.73 | 2.33 |
| P/B Ratio (TTM) | 0.59 | 2.87 |
| P/FCF Ratio (TTM) | -7.20 | 16.15 |
| Price to 5YR AVG Earnings Ratio | N/A | 9.52 |
| Price to 5YR AVG FCF Ratio | N/A | 46.13 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.51% | 7.07% |
| ROE (TTM) | -0.74% | 12.60% |
| Net Profit Margin (TTM) | -0.92% | 7.96% |
| ROIC 5YR AVG | N/A | 10.94% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 25.51% | 50.70% | N/A |
| Revenue | -4.05% | 26.33% | N/A |
| Net Income | 0.45% | 52.30% | N/A |
| Cash Flow | -109.02% | 48.16% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.74 | 2.35 |
| Quick Ratio (TTM) | 3.74 | 2.29 |
| D/E Ratio (TTM) | N/A | 0.31 |
| Interest Coverage (TTM) | N/A | 18.50 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 2.91 | 4.79 |
| LTL to 5YR AVG FCF | N/A | 5.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.49% |